Detecting chromosomal aberrations by array CGH is faster, more robust, and provides superior results over other technologies such as FISH and G-banding karyotyping, providing a greater understanding of the role of chromosomal changes in genetic diseases, pre and postnatal disorders, autism spectrum disorders, and cancers. The proprietary labeling technology in Enzo's array CGH kits, CYTAG®, generates consistent results that exceed industry standards, increasing accuracy of variant detection, minimizing manual data analysis, increasing efficiency, and reducing overall sample analysis time. For array CGH you can rely on, choose Enzo. To learn more please visit enzolifescience.com/cgh
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?